The latest on GLP-1s, metabolic health and the future of employer healthcare.

A Real-World GLP-1 Study: Six-Month Outcomes in 8,127 Women

GLP-1s & Metabolic Health

A Real-World GLP-1 Study: Six-Month Outcomes in 8,127 Women

A new Nature Medicine study of 8127 women, led by University College London, in collaboration with SheMed/eMed Healthcare UK, examined six-month GLP-1 treatment outcomes. Researchers observed dramatic improvements in body weight and metabolic health markers, alongside high treatment retention. This study offers real-world insights into structured, digitally delivered GLP-1 care and the importance of ongoing clinical support.

From the blog

Employer Insights

Beyond the Pharmacy Claim: How Employers Can Evaluate the Broader Impact of GLP-1 Programs

GLP-1 pharmacy costs are easy to see. Their broader impact can be harder to measure. This article looks at how employers can evaluate medical costs, clinical outcomes, medication use, productivity, and longer-term trends alongside pharmacy spend.

September 29, 2026

GLP-1s & Metabolic Health

The Most Important GLP-1 Decision Happens After Treatment Begins

GLP-1 management should not stop at eligibility. Regular clinical evaluation can help employers support participants who are benefiting while identifying when treatment needs to be reassessed.

September 4, 2026

How to Build a GLP-1 ROI Model Your CFO Won't Tear Apart

How to Build a GLP-1 ROI Model Your CFO Won't Tear Apart

The most useful GLP-1 ROI models aren't the ones with the biggest projected return. They're the ones built on transparent assumptions, measurable inputs, and realistic expectations that employers can explain with confidence.

August 14, 2026

The GLP-1 Coverage Debate: What Employers Are Missing | eMed

Employer Insights

The GLP-1 Coverage Debate: What Employers Are Missing

As more employers evaluate GLP-1 coverage, the conversation is shifting beyond drug costs. Learn why adherence, clinical oversight, and program design are becoming central to successful employer GLP-1 strategies.

The Hidden Cost of Chronic Conditions in Today’s Workforce

Employer Insights

The Hidden Cost of Chronic Conditions in Today’s Workforce

Chronic conditions affect more than healthcare spending. As chronic disease becomes increasingly common among working-age adults, employers are facing growing challenges related to productivity, absenteeism, workforce engagement, and long-term healthcare costs.

Medical professional in white coat with stethoscope writing on a clipboard at a desk.

GLP-1s & Metabolic Health

The Evolving Science of Weight Loss

While weight loss remains an important outcome, healthcare providers are increasingly recognizing that weight alone does not tell the full story. Body composition, metabolic health, physical function, and long-term sustainability are becoming important considerations alongside weight loss outcomes.

From Weight Loss to Population Health

Employer Insights

From Weight Loss to Population Health

Insights from the eMed Health Innovation Revolution Summit on chronic disease prevention, engagement, and long-term health outcomes

How to Build a Fitness Routine That Fits Real Life

Nutrition & Lifestyle

How to Build a Fitness Routine That Fits Real Life

Building a sustainable fitness routine does not require perfection or extreme workouts. Learn how flexibility, consistency, and realistic habits can support long-term health and wellbeing.

Why Wellness Challenges Rarely Create Lasting Habits

Employer Insights

Why Wellness Challenges Rarely Create Lasting Habits

Many workplace wellness challenges create short-term motivation but fail to support lasting behavior change. Explore why sustainable employee health requires consistency, accountability, and long-term support.

doctor holding tablet in his hand and writing something

GLP-1s & Metabolic Health

What Is Metabolic Health? Why Does It Matter?

Metabolic health has become a central topic in conversations about chronic disease, healthcare costs, and long-term outcomes.

woman holding a white box labeled Wegovy

GLP-1s & Metabolic Health

GLP-1 Medications: What Employers Should Know

As GLP-1 utilization increases, low adherence and inconsistent treatment management are driving higher employer healthcare costs and variable outcomes.

two medical workers looking in to the tablet

Employer Insights

Why Preventive Care Fails Without Sustained Engagement

Employers are investing in preventive care and GLP-1 medications, but inconsistent utilization and high discontinuation rates are limiting outcomes and increasing long-term costs.

Spring Reset: Why April Is a Turning Point for Employee Health Trends and Healthcare Costs

Employer Insights

Spring Reset: Why April Is a Turning Point for Employee Health Trends

Early-year engagement fades by April, revealing which employee health behaviors persist and which drive long-term healthcare costs.

Feet in light gray socks standing on a white analog weight scale on a black textured floor.

GLP-1s & Metabolic Health

Why GLP-1s Are Changing Obesity Treatment

GLP-1 medications are redefining obesity treatment by addressing the biological drivers of metabolic disease and long-term weight management.

Family of four preparing toast together in a bright kitchen around a large marble countertop.

Nutrition & Lifestyle

10 Small Nutrition Habits That Make a Bigger Difference Than You Think

Small nutrition habits can influence long term health more than short term diets. Discover 10 practical habits that support balanced nutrition and sustainable eating patterns.

Doctor's hand on tablet with medical icons and data charts overlay in light blue background.

GLP-1s: A Healthcare Market Reset & Industry Disruption

GLP-1 medications are reshaping obesity treatment, metabolic health, and healthcare economics. Why GLP-1s represent a true market reset.

Female doctor with stethoscope looking at her smartphone in a bright office.

Employer Insights

Access to GLP-1 Treatment / Telehealth Solutions

Millions could benefit from GLP-1 medications but face barriers like cost, coverage, and provider shortages. Why access will define the next phase.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.